Exploiting pre-existing viral immunity for B cell vaccination against endogenous antigens
Cancer vaccines are a novel method of treating cancer by harnessing the patient's own immune system to recognise and attack malignant cells. Viral vectors can be used to encode tumour antigens to be presented to the immune system . However this field is hindered by immunity to the viral vectors...
Main Author: | |
---|---|
Other Authors: | |
Published: |
University of Oxford
2013
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.645203 |